Pharmaceutical AI start-ups are the highest financing industry in the past 5 years, raising a total of 4 billion 300 million dollars.


Pharmaceutical AI start-ups are the highest financing industry in the past 5 years, raising a total of 4 billion 300 million dollars.

Original title: in the pharmaceutical field, AI start-ups have become the highest financing industry, raising 4 billion 300 million dollars in 5 years.

PingWest, Sept. 14, according to VentureBeat, CB Insight's latest report on artificial intelligence in healthcare shows that AI startups in healthcare have completed 576 rounds of financing since 2013, raising $4.3 billion, more than any other industry. In addition, since the first half of 2018, China has surpassed the United Kingdom to become one of the most active countries in the field of health care AI venture financing transactions.

Pharmaceutical companies are increasingly interested in artificial intelligence, especially start-ups that focus on using AI to speed up drug development, the report says. In May 2018, Pfizer established a strategic partnership with XtalPi, a company that develops drug designs based on computational rationality. International pharmaceutical giants, including Novartis, Sanofi, GlaxoSmithKline, Amgen and Merck, are also moving in this direction.


Waonews is a news media from China, with hundreds of translations, rolling updates China News, hoping to get the likes of foreign netizens